SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 77 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $27,000 | +12.5% | 105,798 | +1.3% | 0.00% | – |
| Q1 2016 | $24,000 | -85.1% | 104,420 | -77.4% | 0.00% | – |
| Q4 2015 | $161,000 | +109.1% | 461,700 | +926.8% | 0.00% | – |
| Q3 2015 | $77,000 | +60.4% | 44,967 | +105.9% | 0.00% | – |
| Q2 2015 | $48,000 | -91.6% | 21,836 | -92.6% | 0.00% | – |
| Q1 2015 | $573,000 | -42.4% | 295,726 | -21.3% | 0.00% | -100.0% |
| Q4 2014 | $994,000 | -13.0% | 375,726 | -1.1% | 0.00% | 0.0% |
| Q3 2014 | $1,142,000 | -39.9% | 380,056 | -18.3% | 0.00% | 0.0% |
| Q2 2014 | $1,901,000 | -9.5% | 465,237 | -4.6% | 0.00% | 0.0% |
| Q1 2014 | $2,101,000 | -38.5% | 487,875 | -25.2% | 0.00% | -50.0% |
| Q4 2013 | $3,416,000 | -27.4% | 652,298 | -12.6% | 0.00% | -33.3% |
| Q3 2013 | $4,704,000 | – | 746,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |